Biomaterials, biological molecules, and polymers in developing vaccines.

Area of Science:

• Biomaterials Science
• Vaccinology
• Bioengineering

Background:

• Traditional vaccines face manufacturing, storage, and immunogenicity challenges, often requiring adjuvants and boosters.
• Existing vaccine strategies struggle with large-scale production and suboptimal immune responses for certain diseases like cancer.

Purpose of the Study:

• To explore bioengineering techniques for developing advanced biomaterial-based vaccines.
• To review design principles, regulatory considerations, and limitations of biomaterial vaccines.
• To discuss future clinical applications of biomaterial vaccine technology.

Main Methods:

• Review of current bioengineering techniques utilizing hydrogels, modified polymers, cell membranes, self-assembled proteins, virus-like particles (VLPs), and nucleic acids.
• Analysis of design principles and regulatory landscapes for biomaterial vaccine development.
• Critical assessment of limitations and potential solutions for biomaterial vaccines.

Main Results:

• Biomaterials offer unique functionalities for vaccine delivery and development.
• Various biomaterials, including hydrogels, VLPs, and nucleic acids, show promise for vaccine applications.
• Design principles and regulatory pathways are crucial for successful clinical translation.

Conclusions:

• Biomaterial-based vaccines represent a promising alternative to conventional vaccines.
• Overcoming limitations in immunogenicity and production is key to clinical success.
• Further research and development hold significant potential for future therapeutic and preventative applications.